| Patient No. | Response to the initial increased dose bortezomib therapy | Successive treatments after the initial increased bortezomib treatment | Treatment duration of the second increased dose bortezomib treatment (months) |
| 1 | PD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 4 |
| 2 | * | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 8## |
| 3 | SD | - | * |
| 4 | SD | # | * |
| 5 | SD | # | * |
| 6 | SD | - | * |
| 7 | SD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 2## |
| 8 | SD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 9## |
| 9 | * | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 7## |
| 10 | * | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 6 |
| 11 | PD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 9## |
| 12 | PD | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 13## |
| 13 | * | - | * |
| 14 | * | BDT50 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/body on Days 1-2, and Tha 50 mg/body on Days 1-28 | 3 |
| 15 | PD | BDL15 Bor 1.6 mg/m2 on Day 1, Dex 20 mg/m2 on Days 1-2, and Len 15 mg/body on Days 1-28 | 3 |
| 16 | SD | - | * |
| 17 | PD | - | * |
| 18 | * | BD Bor 1.6 mg/m2 on Day 1 and Dex 20 mg/body on Days 1-2 | 1 |
| 19 | SD | # | * |
| 20 | PD | # | * |
| 21 | * | # | * |
| 22 | PD | - | * |